Hillstream BioPharma, Inc. (NASDAQ:HILS – Get Free Report) shares traded down 1.4% during mid-day trading on Thursday . The company traded as low as $1.41 and last traded at $1.44. 17,521 shares traded hands during trading, a decline of 99% from the average session volume of 1,388,685 shares. The stock had previously closed at $1.46.
Hillstream BioPharma Trading Up 3.7 %
The company has a 50-day simple moving average of $1.74 and a 200 day simple moving average of $2.02. The company has a market cap of $24.82 million, a P/E ratio of -1.96 and a beta of 3.08.
Hillstream BioPharma Company Profile
Hillstream BioPharma, Inc, a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death (IMCD) and targeted immuno-oncology novel biologics for the treatment drug resistant cancers. The company's product candidate is HSB-1216, an IMCD inducer targeting solid tumors.
Recommended Stories
- Five stocks we like better than Hillstream BioPharma
- Utilities Stocks Explained – How and Why to Invest in Utilities
- MarketBeat Week in Review – 03/24 – 03/28
- Insider Buying Explained: What Investors Need to Know
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- Stock Splits, Do They Really Impact Investors?
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Hillstream BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hillstream BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.
